Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 288
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02564952 | An Open-label Extension Study to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol | ||
| NCT03032016 | European VOD Registry | ||
| NCT05091567 | A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer | ||
| NCT02365610 | A Study of GWP42006 in People With Focal Seizures - Part B | ||
| NCT05864846 | A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex | ||
| NCT04526288 | CPX-351 Versus Immediate Stem Cell Transplantation for the Treatment of High-Grade Myeloid Cancers With Measurable Residual Disease | ||
| NCT04571645 | Dociparstat in Combination With Standard Chemotherapy for the Treatment of Acute Myeloid Leukemia | ||
| NCT02006628 | A Study of GWP42003 as Adjunctive Therapy in the First Line Treatment of Schizophrenia or Related Psychotic Disorder | ||
| NCT00371137 | A Safety and Efficacy Study of Xyrem® in Subjects With Fibromyalgia | ||
| NCT04231851 | CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid Leukemia | ||
| NCT02525692 | Oral ONC201 in Adult Recurrent Glioblastoma | ||
| NCT05099666 | Lurbinectedin + Doxorubicin In Leiomyosarcoma | ||
| NCT05772429 | Long-Term Follow-Up of a Cohort of Participants Prescribed Epidyolex in France in a Real-life Setting | ||
| NCT01610700 | An Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Patients | ||
| NCT00132873 | Trial of Xyrem® (Sodium Oxybate) for the Treatment of Narcolepsy | ||
| NCT00628498 | Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study | ||
| NCT03532035 | Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus Viremia | ||
| NCT07102381 | A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer | ||
| NCT03954106 | A Safety and Efficacy Study of Defibrotide in the Prevention of Chimeric Antigen Receptor-T-cell-associated Neurotoxicity | ||
| NCT05720494 | A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JZP441 in Healthy Participants | ||
| NCT02238925 | An Open Label Phase II Pharmacokinetic and Pharmacodynamic Assessment of the Potential for QTc Prolongation Following First Induction Treatment With CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in Acute Leukemias and MDS Patients | ||
| NCT04291937 | A Multicenter Expanded Access Treatment Protocol of Lurbinectedin in Previously Treated SCLC in the USA | ||
| NCT06113237 | Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy | ||
| NCT06961266 | A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1 | ||
| NCT02038699 | A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer | ||
| NCT00358501 | Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients | ||
| NCT05178316 | A Study of JZP150 in Adults With Posttraumatic Stress Disorder | ||
| NCT04485104 | Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures | ||
| NCT02607904 | An Open-label Extension Trial to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy | ||
| NCT06695845 | A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors | ||
| NCT01322464 | Study to Assess Food Effect on Sativex Bioavailability | ||
| NCT03555955 | A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351 | ||
| NCT05631327 | A JZP341 Study in Adult Participants With Advanced or Metastatic Solid Tumors | ||
| NCT04803786 | A Patient-Centric, Prospective, Observational, Non-Interventional Switch Study of XYWAV in Narcolepsy | ||
| NCT01812603 | A Safety Study of Sativex in Combination With Dose-intense Temozolomide in Patients With Recurrent Glioblastoma | ||
| NCT05122650 | A Study To Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential Tremor (ET) | ||
| NCT03526926 | A Post-Marketing Observational Study of VYXEOS™ | ||
| NCT07290985 | AACR Adaptive Biomarker-Driven Organ Preservation Trial in Gastroesophageal Adenocarcinomas | ||
| NCT04899947 | Child and Adolescent Registry for Participants With Narcolepsy | ||
| NCT07192068 | Clinical Trial Evaluating the Activity of Zanidatamab for the Treatment of Patients With Solid Tumors With an Alteration of the HER2 Gene. | ||
| NCT00594945 | Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures | ||
| NCT02091375 | Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1) | ||
| NCT03339401 | The AdAPT Trial; Adenovirus After Allogeneic Pediatric Transplantation | ||
| NCT04425655 | Fludarabine in Combination With Daunorubicin and Cytarabine Liposome in Newly-diagnosed Acute Myeloid Leukemia. | ||
| NCT06012929 | A Study of ONC201 for Refractory Meningioma | ||
| NCT05391724 | Safety and Pharmacokinetics of CMX001 in Impaired Hepatic Function and Healthy Subjects | ||
| NCT05476939 | Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0 | ||
| NCT03904251 | CPX-351 and Gemtuzumab Ozogamicin in Treating Patients With Relapsed Acute Myeloid Leukemia | ||
| NCT02596997 | Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease | ||
| NCT07176312 | Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) Patients |
